Company Overview - Loyal 公司致力于延长犬类的寿命和提高其健康水平 [1] - Loyal 公司已从顶级投资者处筹集了 1亿3500万美元 (135 million) 用于研发犬类长寿药 [1] Regulatory Outlook - Loyal 公司预计明年将获得 FDA 的首次有条件批准 [1]

Company Focus - Loyal 公司致力于延长犬类的寿命和提高其健康水平 [1] - Loyal 公司已从顶级投资者处筹集 1.35 亿美元资金 [1] Regulatory Outlook - Loyal 公司预计明年将获得 FDA 的首次有条件批准 [1]

Company Overview - Loyal 公司致力于研发延长犬类寿命的药物 [1] - Loyal 公司已从顶级投资者处筹集 135 million 美元资金 [1] Product Development - Loyal 公司正在开发犬类长寿药丸 [1] Founder - Celine Halioua 是 Loyal 公司的创始人 [1]

Company Overview - Celine Halioua's company has raised $135 million to develop canine longevity pills [1] Product Development - The company anticipates receiving its first conditional approval from the FDA next year for its canine longevity pills [1] Financial Highlights - The company has secured $135 million (135 million 美元) in funding from top investors [1]

Company Overview - Loyal 公司致力于研发延长犬类寿命的药物 [1] - Loyal 公司创始人 Celine Halioua 已经从顶级投资者那里筹集了 135 million 美元 [1] Funding - Loyal 公司已获得 135 million 美元的投资，用于开发犬类长寿药丸 [1]

Funding & Investment - Celine Halioua's company has secured $135 million in funding from prominent investors [1] Product Development & Regulatory Approval - The company is developing canine longevity pills [1] - The company anticipates receiving its first conditional approval from the FDA (Food and Drug Administration) next year [1] Industry Focus - The company's focus is on extending the lifespan of dogs [1]

Company Overview - Loyal 公司致力于研发延长犬类寿命的药物 [1] - Loyal 公司已从顶级投资者处筹集 1.35 亿美元资金 [1] Product Development - Loyal 公司正在开发犬类长寿药丸 [1] Funding - Loyal 公司已获得 1.35 亿美元（$135 million）的融资 [1]

What if dogs could live longer? Celine Halioua has raised $135 million from top investors to develop canine longevity pills—and expects to get her first conditional approval from the FDA next year. https://t.co/XPMe2lfUUh (Photo: Ethan Pines For Forbes) #BillionDollarStartups https://t.co/QMtkigu7m7 ...

Funding & Investment - Celine Halioua's company has raised $135 million from top investors [1] Pharmaceutical Development - The company is developing canine longevity pills [1] - The company expects to get its first conditional approval from the FDA next year [1] Industry Focus - The focus is on extending the lifespan of dogs [1]